Opioid Use Disorder

NEW ORLEANS — At the AAP National Conference & Exhibition, Stephen W. Patrick, MD, MPH, MS, associate professor of pediatrics and health policy at the Vanderbilt School of Medicine, spoke about the providers’ role treating both neonatal opioid withdrawal and the effects on opioids on the entire family.

One-fifth of patients were prescribed opioids after cardiac implantable electronic device procedures, most of whom were opioid naive, according to a study published in HeartRhythm.

The rates of hepatitis C infection at delivery among pregnant women in the U.S. increased between 2000 and 2015, especially among women with concomitant opioid use disorder, the prevalence of which also increased during that period.

Results from a real-world study of implementing hepatitis C testing into integrated care centers that deliver HIV services to people who inject drugs demonstrated superior infection awareness, testing and treatment compared with usual care.

Results from a study presented at Psych Congress suggested that lofexidine can effectively mitigate symptoms of opioid withdrawal syndrome during peak withdrawal — a “critical period” for treating opioid withdrawal symptoms and transition to treatment for opioid use disorder.

Hypogonadism occurs in more than half of men using opioids, and hypocortisolism occurs in approximately one-fifth of all patients, according to findings from a meta-analysis of more than 50 studies.

SAN DIEGO — Thomas Kosten, MD, Waggoner Chair and Professor of Psychiatry, Pharmacology, Immunology, and Neuroscience, and director of the division of addictions at Baylor College of Medicine, spoke about the potential of nonopioid alternatives for chronic pain in a video interview.

SAN DIEGO — In a video interview, Arwen Podesta, MD, ABPN, FASAM, ABIHM, a board-certified adult psychiatrist of Podesta Wellness in New Orleans, spoke about her presentation on implementing buprenorphine into psychiatric practice.

An assessment of sexual risk behaviors, as they relate to viral suppression, from before, during and after incarceration among persons living with HIV and alcohol use or opioid use disorders demonstrated that the risk of HIV transmission among this population is low.

Researchers identified any high-frequency prescription drug misuse during the transition from